Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-02

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the impact of table grape consumption on gut microbiome, intestinal permeability, systemic inflammation, and vascular function in healthy overweight men and women aged 45-70 years. The main questions it aims to answer are:

* Does daily grape intake alter intestinal microbiome composition and intestinal permeability?
* Are changes in gut microbiota and intestinal permeability correlated with changes in cardiometabolic risk factors (inflammation, vascular function, lipid profiles)?
* Does response to grape intake on gut microbiota, intestinal permeability, cardiometabolic and inflammatory markers differ between men and women?
* Are metabolic pathways modified by grape consumption able to explain the link between gut health and cardiometabolic factors?

Researchers will compare freeze-dried grape powder to placebo powder to see if grape powder improves cardiometabolic risk factors.

Participants will

* Consume the powder dissolved in water twice daily for 3 weeks
* Follow their usual diet, modified to limit polyphenol-rich foods
* Visit the clinic at the beginning and end of the intervention for vascular measurements and blood sample collection
* Complete a 3-day 24-hour dietary recall and collect stool sample before each visit

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

NCT07231484

Obesity &Amp; Overweight

RECRUITING NA

The Effects Grapes on Health Indices

NCT01674231

Obesity Inflammation Cardiovascular Disease +1 more

COMPLETED NA

The Effects of Freeze-Dried Whole Grape Powder on Chronic Disease and Cardiovascular Risk Factors-a Pilot Study

NCT06006182

Healthy People

COMPLETED NA

Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome

NCT02542176

Metabolic Syndrome X

COMPLETED NA

Metabolic Response to Chardonnay Grape Marc Powder

NCT03203915

Dyslipidemia Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will limit intake of grapes and other polyphenol-rich foods while following their usual diet during the 1-week run-in period before the start of the intervention. They will be randomized to start with either grape or placebo powder for 3 weeks, consuming 48 grams of freeze-dried grape powder or placebo dissolved in water twice daily. Compliance will be assessed with three 24-hour dietary recalls using ASA24 and follow-up contact. After a 3- to 4-week washout period, participants will crossover to the other intervention. Study outcomes and anthropometry will be measured on the first and last days of each intervention arm.

Aim 1: Biomarkers to assess the permeability of the gut, including zonulin, lipopolysaccharide (LPS), LPS-binding protein (LBP), soluble CD14, and diamine oxidase (DAO), will be analyzed from blood samples. Gut microbiome profiling will be analyzed from 16S rRNA gene sequencing of fecal samples collected by participants at the beginning and end of each intervention arm.

Aim 2: Vascular function will be assessed by measuring blood pressure and pulse wave velocity. After 15 minutes of rest, blood pressure will be measured three times, with the average of the latter two recorded. Pulse wave velocity from the carotid to femoral artery will measure arterial stiffness. Inflammatory cytokines will be assayed from blood samples to include Th17 cytokines. Lipid panel and comprehensive metabolic panels will also be analyzed.

Aim 3: Sex differences in response to grape consumption will be assessed, including gut microbiome, gut permeability, vascular function, inflammation, lipid profile, and metabolomic pathways. Gender and time interactions will be determined to assess differences in trajectory of changes.

Aim 4: LC-MS will be used for untargeted metabolomics and lipidomics. Pathway analysis will assess metabolic pathways affected by grape consumption and their links to gut permeability, systemic inflammation, and vascular function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Stiffness Blood Pressure Dysbiosis Inflammation Permeability; Increased

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will limit intake of grapes and other polyphenol-rich foods while following their usual diet during the 1-week run-in period before the start of the intervention. They will be randomized to start with either grape or placebo powder for 3 weeks, consuming 48 grams of freeze-dried grape powder or placebo dissolved in water twice daily. Compliance will be assessed with three 24-hour dietary recalls using ASA24 and follow-up contact. After a 3-week washout period, participants will crossover to the other intervention. Study outcomes and anthropometry will be measured on the first and last days of each intervention arm, with the study lasting approximately 10-11 weeks for participants.

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Freeze-dried grape powder or placebo powder packets labeled "A" and "1".

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Grape, Then Placebo

Participants consume 48 grams of freeze-dried grape powder (dissolved into water) twice daily for 3 weeks. After a washout period of at least 3 weeks, participants then consume 48 grams of placebo powder matching grape powder (dissolved into water) twice daily for 3 weeks.

Group Type EXPERIMENTAL

Freeze-dried grape powder

Intervention Type DIETARY_SUPPLEMENT

48 grams powder

Placebo powder

Intervention Type OTHER

48 grams powder

Placebo, Then Grape

Participants consume 48 grams of placebo powder matching grape powder (dissolved into water) twice daily for 3 weeks. After a washout period of at least 3 weeks, participants then consume 48 grams of freeze-dried grape powder (dissolved into water) twice daily for 3 weeks.

Group Type EXPERIMENTAL

Freeze-dried grape powder

Intervention Type DIETARY_SUPPLEMENT

48 grams powder

Placebo powder

Intervention Type OTHER

48 grams powder

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Freeze-dried grape powder

48 grams powder

Intervention Type DIETARY_SUPPLEMENT

Placebo powder

48 grams powder

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* post-menopausal women (cessation of menstruation for minimum two years)
* overweight and obese (BMI between 25-35 kg/m2)
* stable treatment for type 2 diabetes or metabolic syndrome
* ability to understand the intervention concept and written consent to participate
* willingness to accept randomization, undergo testing and intervention procedures, and deliver stool and blood samples

Exclusion Criteria

* menopausal hormone replacement therapy started within less than 6 months
* antibiotics, prebiotics within last 3 months
* antidiabetic treatment involving insulin (for type 1 diabetes)
* vegetarian/vegan and not able to follow modified diet
* any serious medical condition including but not limited to coronary artery disease, uncontrolled hypertension, stroke, congestive heart failure, insulin-dependent diabetes, liver disease, active cancer and anemia
* psychiatric disease that interferes with the understanding and implementation of the intervention
* history of eating disorders such as bulimia nervosa, anorexia nervosa, severe binge eating disorder in the last 5 years
* history of substance abuse or alcohol abuse
* involvement in a weight loss intervention program (including anti-obesity medication) within last 3 months or have had bariatric surgery
* current smokers (within last 180 days)
* use of dietary supplements containing polyphenols in the past 1 month
* strenuous exercise greater than 10 hours per week

Minimum Eligible Age

45 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes